The DOI matches its Crossref record; 228 of the 228 references it cites were found in a registry or an index.
Fanconi anaemia and cancer: an intricate relationship
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004088 · Cited by 15,160
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Bryant, H. E., Schultz, N., Thomas, H. D., Parker, K. M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N. J., & Helleday, T. (2005) · Nature · doi:10.1038/nature03443 · Cited by 5,198
Cell cycle, CDKs and cancer: a changing paradigm
Malumbres, M., & Barbacid, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2602 · Cited by 3,957
Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
Identification of the breast cancer susceptibility gene BRCA2
Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S., Gumbs, C., Micklem, G., et al. (1995) · Nature · doi:10.1038/378789a0 · Cited by 3,645
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers
Fong, P. C., Boss, D. S., Yap, T. A., Tutt, A., Wu, P., Mergui-Roelvink, M., Mortimer, P., Swaisland, H., Lau, A., O'Connor, M. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900212 · Cited by 3,634
Modulation of oxidative stress as an anticancer strategy
Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579
Oxidative stress: a concept in redox biology and medicine
Sies, H. (2015) · Redox Biology · doi:10.1016/j.redox.2015.01.002 · Cited by 2,991
PARP inhibitors: Synthetic lethality in the clinic
Lord, C. J., & Ashworth, A. (2017) · Science · doi:10.1126/science.aam7344 · Cited by 2,880
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
Topalian, S. L., Taube, J. M., Anders, R. A., & Pardoll, D. M. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.36 · Cited by 2,733
ATM, ATR, and DNA-PK: The Trinity at the Heart of the DNA Damage Response
Blackford, A. N., & Jackson, S. P. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.05.015 · Cited by 1,961
Variation in cancer risk among tissues can be explained by the number of stem cell divisions
Tomasetti, C., & Vogelstein, B. (2015) · Science · doi:10.1126/science.1260825 · Cited by 1,927
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
Ledermann, J., Harter, P., Gourley, C., Friedlander, M., Vergote, I., Rustin, G., Scott, C., Meier, W., Shapira-Frommer, R., Safra, T., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1105535 · Cited by 1,883
Cell cycle proteins as promising targets in cancer therapy
Otto, T., & Sicinski, P. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.138 · Cited by 1,858
Pujade-Lauraine, E., Ledermann, J. A., Selle, F., Gebski, V., Penson, R. T., Oza, A. M., Korach, J., Huzarski, T., Poveda, A., Pignata, S., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30469-2 · Cited by 1,855
Meta-Analysis of BRCA1 and BRCA2 Penetrance
Chen, S., & Parmigiani, G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.1066 · Cited by 1,802
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation
Kaufman, B., Shapira-Frommer, R., Schmutzler, R. K., Audeh, M. W., Friedlander, M., Balmaña, J., Mitchell, G., Fried, G., Stemmer, S. M., Hubert, A., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.2728 · Cited by 1,671
Ledermann, J., Harter, P., Gourley, C., Friedlander, M., Vergote, I., Rustin, G., Scott, C. L., Meier, W., Shapira-Frommer, R., Safra, T., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70228-1 · Cited by 1,442
A mechanism linking extra centrosomes to chromosomal instability
Ganem, N. J., Godinho, S. A., & Pellman, D. (2009) · Nature · doi:10.1038/nature08136 · Cited by 1,422
The Bloom's syndrome gene product is homologous to RecQ helicases
Ellis, N. A., Groden, J., Ye, T.-Z., Straughen, J., Lennon, D. J., Ciocci, S., Proytcheva, M., & German, J. (1995) · Cell · doi:10.1016/0092-8674(95)90105-1 · Cited by 1,403
Germline Mutations in Predisposition Genes in Pediatric Cancer
Zhang, J., Walsh, M. F., Wu, G., Edmonson, M. N., Gruber, T. A., Easton, J., Hedges, D., Ma, X., Zhou, X., Yergeau, D. A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1508054 · Cited by 1,345
Revisiting the hallmarks of cancer.
Fouad, Y. A., & Aanei, C. M. (2017) · Europe PMC (PubMed Central) · Cited by 1,245
DNA breaks and chromosome pulverization from errors in mitosis
Crasta, K., Ganem, N. J., Dagher, R., Lantermann, A. B., Ivanova, E. V., Pan, Y., Nezi, L., Protopopov, A., Chowdhury, D., & Pellman, D. (2012) · Nature · doi:10.1038/nature10802 · Cited by 1,227
Interaction of the Fanconi Anemia Proteins and BRCA1 in a Common Pathway
Garcia-Higuera, I., Taniguchi, T., Ganesan, S., Meyn, M. S., Timmers, C., Hejna, J., Grompe, M., & D'Andrea, A. D. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00173-3 · Cited by 1,198
Biallelic Inactivation of BRCA2 in Fanconi Anemia
Howlett, N. G., Taniguchi, T., Olson, S., Cox, B., Waisfisz, Q., de Die-Smulders, C., Persky, N., Grompe, M., Joenje, H., Pals, G., et al. (2002) · Science · doi:10.1126/science.1073834 · Cited by 1,149
DNA interstrand crosslink repair and cancer
Deans, A. J., & West, S. C. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3088 · Cited by 1,023
Schlacher, K., Wu, H., & Jasin, M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.05.015 · Cited by 936
Carcinogenicity of alcoholic beverages
Baan, R., Straif, K., Grosse, Y., Secretan, B., El Ghissassi, F., Bouvard, V., Altieri, A., & Cogliano, V. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70099-2 · Cited by 877
Control of BRCA2 Cellular and Clinical Functions by a Nuclear Partner, PALB2
Xia, B., Sheng, Q., Nakanishi, K., Ohashi, A., Wu, J., Christ, N., Liu, X., Jasin, M., Couch, F. J., & Livingston, D. M. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.05.022 · Cited by 861
Epigenetic modulators, modifiers and mediators in cancer aetiology and progression
Feinberg, A. P., Koldobskiy, M. A., & Göndör, A. (2016) · Nature Reviews Genetics · doi:10.1038/nrg.2016.13 · Cited by 841
Causes and consequences of aneuploidy in cancer
Gordon, D. J., Resio, B., & Pellman, D. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3123 · Cited by 815
The Fanconi anaemia pathway: new players and new functions
Ceccaldi, R., Sarangi, P., & D'Andrea, A. D. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.48 · Cited by 720
Identification of the FANCI Protein, a Monoubiquitinated FANCD2 Paralog Required for DNA Repair
Smogorzewska, A., Matsuoka, S., Vinciguerra, P., McDonald, E. R., Hurov, K. E., Luo, J., Ballif, B. A., Gygi, S. P., Hofmann, K., D'Andrea, A. D., et al. (2007) · Cell · doi:10.1016/j.cell.2007.03.009 · Cited by 700
Mutations in RECQL4 cause a subset of cases of Rothmund-Thomson syndrome
Kitao, S., Shimamoto, A., Goto, M., Miller, R. W., Smithson, W. A., Lindor, N. M., & Furuichi, Y. (1999) · Nature Genetics · doi:10.1038/8788 · Cited by 666
Substantial contribution of extrinsic risk factors to cancer development
Wu, S., Powers, S., Zhu, W., & Hannun, Y. A. (2016) · Nature · doi:10.1038/nature16166 · Cited by 666
Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer
Reid, S., Schindler, D., Hanenberg, H., Barker, K., Hanks, S., Kalb, R., Neveling, K., Kelly, P., Seal, S., Freund, M., et al. (2007) · Nature Genetics · doi:10.1038/ng1947 · Cited by 642
Exit from dormancy provokes DNA-damage-induced attrition in haematopoietic stem cells
Walter, D., Lier, A., Geiselhart, A., Thalheimer, F. B., Huntscha, S., Sobotta, M. C., Moehrle, B., Brocks, D., Bayindir, I., Kaschutnig, P., et al. (2015) · Nature · doi:10.1038/nature14131 · Cited by 619
A 20-year perspective on the International Fanconi Anemia Registry (IFAR)
Kutler, D. I., Singh, B., Satagopan, J., Batish, S. D., Berwick, M., Giampietro, P. F., Hanenberg, H., & Auerbach, A. D. (2003) · Blood · doi:10.1182/blood-2002-07-2170 · Cited by 618
Replication stress induces sister-chromatid bridging at fragile site loci in mitosis
Chan, K. L., Palmai-Pallag, T., Ying, S., & Hickson, I. D. (2009) · Nature Cell Biology · doi:10.1038/ncb1882 · Cited by 612
The Deubiquitinating Enzyme USP1 Regulates the Fanconi Anemia Pathway
Nijman, S. M. B., Huang, T. T., Dirac, A. M. G., Brummelkamp, T. R., Kerkhoven, R. M., D'Andrea, A. D., & Bernards, R. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.01.008 · Cited by 588
Helmrich, A., Ballarino, M., & Tora, L. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.10.013 · Cited by 574
A novel ubiquitin ligase is deficient in Fanconi anemia
Meetei, A. R., de Winter, J. P., Medhurst, A. L., Wallisch, M., Waisfisz, Q., van de Vrugt, H. J., Oostra, A. B., Yan, Z., Ling, C., Bishop, C. E., et al. (2003) · Nature Genetics · doi:10.1038/ng1241 · Cited by 568
Fanconi anemia and its diagnosis
Auerbach, A. D. (2009) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2009.01.013 · Cited by 562
Pathophysiology and management of inherited bone marrow failure syndromes
Shimamura, A., & Alter, B. P. (2010) · Blood Reviews · doi:10.1016/j.blre.2010.03.002 · Cited by 552
ALDEHYDE DEHYDROGENASE DEFICIENCY AS CAUSE OF FACIAL FLUSHING REACTION TO ALCOHOL IN JAPANESE
Harada, S., Agarwal, D. P., & Goedde, H. W. (1981) · The Lancet · doi:10.1016/s0140-6736(81)91172-7 · Cited by 539
Disruption of the Fanconi anemia–BRCA pathway in cisplatin-sensitive ovarian tumors
Taniguchi, T., Tischkowitz, M., Ameziane, N., Hodgson, S. V., Mathew, C. G., Joenje, H., Mok, S. C., & D'Andrea, A. D. (2003) · Nature Medicine · doi:10.1038/nm852 · Cited by 536
Kim, G., Ison, G., McKee, A. E., Zhang, H., Tang, S., Gwise, T., Sridhara, R., Lee, E., Tzou, A., Philip, R., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0887 · Cited by 528
Fancd2 counteracts the toxic effects of naturally produced aldehydes in mice
Langevin, F., Crossan, G. P., Rosado, I. V., Arends, M. J., & Patel, K. J. (2011) · Nature · doi:10.1038/nature10192 · Cited by 500
Konstantinopoulos, P. A., Spentzos, D., Karlan, B. Y., Taniguchi, T., Fountzilas, E., Francoeur, N., Levine, D. A., & Cannistra, S. A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.5719 · Cited by 483
Brooks, P. J., Enoch, M.-A., Goldman, D., Li, T.-K., & Yokoyama, A. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000050 · Cited by 480
Bradford, P. T., Goldstein, A. M., Tamura, D., Khan, S. G., Ueda, T., Boyle, J., Oh, K.-S., Imoto, K., Inui, H., Moriwaki, S.-I., et al. (2011) · Journal of Medical Genetics · doi:10.1136/jmg.2010.083022 · Cited by 480
Convergence of the Fanconi Anemia and Ataxia Telangiectasia Signaling Pathways
Taniguchi, T., Garcia-Higuera, I., Xu, B., Andreassen, P. R., Gregory, R. C., Kim, S.-T., Lane, W. S., Kastan, M. B., & D'Andrea, A. D. (2002) · Cell · doi:10.1016/s0092-8674(02)00747-x · Cited by 449
The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J
Levitus, M., Waisfisz, Q., Godthelp, B. C., Vries, Y. D., Hussain, S., Wiegant, W. W., Elghalbzouri-Maghrani, E., Steltenpool, J., Rooimans, M. A., Pals, G., et al. (2005) · Nature Genetics · doi:10.1038/ng1625 · Cited by 432
Mutation of the RAD51C gene in a Fanconi anemia–like disorder
Vaz, F., Hanenberg, H., Schuster, B., Barker, K., Wiek, C., Erven, V., Neveling, K., Endt, D., Kesterton, I., Autore, F., et al. (2010) · Nature Genetics · doi:10.1038/ng.570 · Cited by 408
ATR couples FANCD2 monoubiquitination to the DNA-damage response
Andreassen, P. R., D'Andrea, A. D., & Taniguchi, T. (2004) · Genes & Development · doi:10.1101/gad.1196104 · Cited by 408
Genotoxic consequences of endogenous aldehydes on mouse haematopoietic stem cell function
Garaycoechea, J. I., Crossan, G. P., Langevin, F., Daly, M., Arends, M. J., & Patel, K. J. (2012) · Nature · doi:10.1038/nature11368 · Cited by 387
Endogenous Formaldehyde Is a Hematopoietic Stem Cell Genotoxin and Metabolic Carcinogen
Pontel, L. B., Rosado, I. V., Burgos-Barragan, G., Garaycoechea, J. I., Yu, R., Arends, M. J., Chandrasekaran, G., Broecker, V., Wei, W., Liu, L., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.08.020 · Cited by 382
The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia
Levran, O., Attwooll, C., Henry, R. T., Milton, K. L., Neveling, K., Rio, P., Batish, S. D., Kalb, R., Velleuer, E., Barral, S., et al. (2005) · Nature Genetics · doi:10.1038/ng1624 · Cited by 370
High Incidence of Head and Neck Squamous Cell Carcinoma in Patients With Fanconi Anemia
Kutler, D. I., Auerbach, A. D., Satagopan, J., Giampietro, P. F., Batish, S. D., Huvos, A. G., Goberdhan, A., Shah, J. P., & Singh, B. (2003) · Archives of Otolaryngology–Head & Neck Surgery · doi:10.1001/archotol.129.1.106 · Cited by 370
The Fanconi Anemia Pathway Maintains Genome Stability by Coordinating Replication and Transcription
Schwab, R. A., Nieminuszczy, J., Shah, F., Langton, J., Lopez Martinez, D., Liang, C.-C., Cohn, M. A., Gibbons, R. J., Deans, A. J., & Niedzwiedz, W. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.09.012 · Cited by 361
Blunt, T., Gell, D., Fox, M., Taccioli, G. E., Lehmann, A. R., Jackson, S. P., & Jeggo, P. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.19.10285 · Cited by 352
Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2
Alter, B. P., Rosenberg, P. S., & Brody, L. C. (2007) · Journal of Medical Genetics · doi:10.1136/jmg.2006.043257 · Cited by 341
Ceccaldi, R., Parmar, K., Mouly, E., Delord, M., Kim, J. M., Regairaz, M., Pla, M., Vasquez, N., Zhang, Q.-S., Pondarre, C., et al. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.05.013 · Cited by 340
Wang, L. L., Gannavarapu, A., Kozinetz, C. A., Levy, M. L., Lewis, R. A., Chintagumpala, M. M., Ruiz-Maldanado, R., Contreras-Ruiz, J., Cunniff, C., Erickson, R. P., et al. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.9.669 · Cited by 338
Naim, V., & Rosselli, F. (2009) · Nature Cell Biology · doi:10.1038/ncb1883 · Cited by 338
Flavonoids as Cytokine Modulators: A Possible Therapy for Inflammation-Related Diseases
Leyva-López, N., Gutierrez-Grijalva, E., Ambriz-Perez, D., & Heredia, J. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17060921 · Cited by 337
Smogorzewska, A., Desetty, R., Saito, T. T., Schlabach, M., Lach, F. P., Sowa, M. E., Clark, A. B., Kunkel, T. A., Harper, J. W., Colaiácovo, M. P., et al. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.023 · Cited by 334
Alter, B. P., Giri, N., Savage, S. A., Peters, J. A., Loud, J. T., Leathwood, L., Carr, A. G., Greene, M. H., & Rosenberg, P. S. (2010) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08212.x · Cited by 324
Abnormal Cytokinesis in Cells Deficient in the Breast Cancer Susceptibility Protein BRCA2
Daniels, M. J., Wang, Y., Lee, M., & Venkitaraman, A. R. (2004) · Science · doi:10.1126/science.1102574 · Cited by 319
Signalling dynamics in the spindle checkpoint response
London, N., & Biggins, S. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3888 · Cited by 308
Mutations in ERCC4, Encoding the DNA-Repair Endonuclease XPF, Cause Fanconi Anemia
Bogliolo, M., Schuster, B., Stoepker, C., Derkunt, B., Su, Y., Raams, A., Trujillo, J. P., Minguillón, J., Ramírez, M. J., Pujol, R., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.04.002 · Cited by 307
Loss of centrosome integrity induces p38—p53—p21-dependent G1—S arrest
Mikule, K., Delaval, B., Kaldis, P., Jurcyzk, A., Hergert, P., & Doxsey, S. (2007) · Nature Cell Biology · doi:10.1038/ncb1529 · Cited by 306
Preventing Nonhomologous End Joining Suppresses DNA Repair Defects of Fanconi Anemia
Adamo, A., Collis, S. J., Adelman, C. A., Silva, N., Horejsi, Z., Ward, J. D., Martinez-Perez, E., Boulton, S. J., & La Volpe, A. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.06.026 · Cited by 302
SLX4, a coordinator of structure-specific endonucleases, is mutated in a new Fanconi anemia subtype
Stoepker, C., Hain, K., Schuster, B., Hilhorst-Hofstee, Y., Rooimans, M. A., Steltenpool, J., Oostra, A. B., Eirich, K., Korthof, E. T., Nieuwint, A. W. M., et al. (2011) · Nature Genetics · doi:10.1038/ng.751 · Cited by 299
Mutations of the SLX4 gene in Fanconi anemia
Kim, Y., Lach, F. P., Desetty, R., Hanenberg, H., Auerbach, A. D., & Smogorzewska, A. (2011) · Nature Genetics · doi:10.1038/ng.750 · Cited by 294
UBE2T Is the E2 in the Fanconi Anemia Pathway and Undergoes Negative Autoregulation
Machida, Y. J., Machida, Y., Chen, Y., Gurtan, A. M., Kupfer, G. M., D'Andrea, A. D., & Dutta, A. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.06.024 · Cited by 291
p21WAF1 and tumourigenesis: 20 years after
Warfel, N. A., & El-Deiry, W. S. (2013) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32835b639e · Cited by 286
Biallelic Mutations in BRCA1 Cause a New Fanconi Anemia Subtype
Sawyer, S. L., Tian, L., Kähkönen, M., Schwartzentruber, J., Kircher, M., University of Washington Centre for Mendelian Genomics, FORGE Canada Consortium, Majewski, J., Dyment, D. A., Innes, A. M., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-1156 · Cited by 283
High expression of DNA repair pathways is associated with metastasis in melanoma patients
Kauffmann, A., Rosselli, F., Lazar, V, Winnepenninckx, V, Mansuet-Lupo, A., Dessen, P., van den Oord, J. J., Spatz, A., & Sarasin, A. (2008) · Oncogene · doi:10.1038/sj.onc.1210700 · Cited by 274
Wang, A. T., Kim, T., Wagner, J. E., Conti, B. A., Lach, F. P., Huang, A. L., Molina, H., Sanborn, E. M., Zierhut, H., Cornes, B. K., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.07.009 · Cited by 273
Oxygen-dependence of chromosomal aberrations in Fanconi's anaemia
Joenje, H., Arwert, F., Eriksson, A. W., de Koning, H., & Oostra, A. B. (1981) · Nature · doi:10.1038/290142a0 · Cited by 273
Rosenberg, P. S., Socié, G., Alter, B. P., & Gluckman, E. (2005) · Blood · doi:10.1182/blood-2004-04-1652 · Cited by 273
ATM and ATR signaling at a glance
Awasthi, P., Foiani, M., & Kumar, A. (2015) · Journal of Cell Science · doi:10.1242/jcs.169730 · Cited by 271
Strub, T., Giuliano, S., Ye, T., Bonet, C., Keime, C., Kobi, D., Le Gras, S., Cormont, M., Ballotti, R., Bertolotto, C., et al. (2011) · Oncogene · doi:10.1038/onc.2010.612 · Cited by 269
Fueling the Cell Division Cycle
Salazar-Roa, M., & Malumbres, M. (2017) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.08.009 · Cited by 268
A selective USP1–UAF1 inhibitor links deubiquitination to DNA damage responses
Liang, Q., Dexheimer, T. S., Zhang, P., Rosenthal, A. S., Villamil, M. A., You, C., Zhang, Q., Chen, J., Ott, C. A., Sun, H., et al. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1455 · Cited by 265
Bloom's Syndrome: Clinical Spectrum, Molecular Pathogenesis, and Cancer Predisposition
Cunniff, C., Bassetti, J. A., & Ellis, N. A. (2017) · Molecular Syndromology · doi:10.1159/000452082 · Cited by 265
Fanconi anemia gene mutations in young-onset pancreatic cancer.
van der Heijden, M. S., Yeo, C. J., Hruban, R. H., & Kern, S. E. (2003) · PubMed · Cited by 264
BRCA1 functions independently of homologous recombination in DNA interstrand crosslink repair
Bunting, S. F., Callén, E., Kozak, M. L., Kim, J. M., Wong, N., López-Contreras, A. J., Ludwig, T., Baer, R., Faryabi, R. B., Malhowski, A., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.02.015 · Cited by 252
Future directions in cancer prevention
Umar, A., Dunn, B. K., & Greenwald, P. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3397 · Cited by 248
Inactivation of Murine Usp1 Results in Genomic Instability and a Fanconi Anemia Phenotype
Kim, J. M., Parmar, K., Huang, M., Weinstock, D. M., Ruit, C. A., Kutok, J. L., & D'Andrea, A. D. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.01.001 · Cited by 247
Mechanism of RAD51-Dependent DNA Interstrand Cross-Link Repair
Long, D. T., Räschle, M., Joukov, V., & Walter, J. C. (2011) · Science · doi:10.1126/science.1204258 · Cited by 241
Draft consensus guidelines for diagnosis and treatment of Shwachman‐Diamond syndrome
Dror, Y., Donadieu, J., Koglmeier, J., Dodge, J., Toiviainen‐Salo, S., Makitie, O., Kerr, E., Zeidler, C., Shimamura, A., Shah, N., et al. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06349.x · Cited by 240
Ku70 Corrupts DNA Repair in the Absence of the Fanconi Anemia Pathway
Pace, P., Mosedale, G., Hodskinson, M. R., Rosado, I. V., Sivasubramaniam, M., & Patel, K. J. (2010) · Science · doi:10.1126/science.1192277 · Cited by 239
An overview of the chemistry and biology of reactive aldehydes
Fritz, K. S., & Petersen, D. R. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.06.025 · Cited by 237
Androgens and liver tumors: Fanconi's anemia and non‐Fanconi's conditions
Velazquez, I., & Alter, B. P. (2004) · American Journal of Hematology · doi:10.1002/ajh.20183 · Cited by 237
Lossaint, G., Larroque, M., Ribeyre, C., Bec, N., Larroque, C., Décaillet, C., Gari, K., & Constantinou, A. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.07.023 · Cited by 232
The mutation spectrum in RECQL4 diseases
Siitonen, H. A., Sotkasiira, J., Biervliet, M., Benmansour, A., Capri, Y., Cormier-Daire, V., Crandall, B., Hannula-Jouppi, K., Hennekam, R., Herzog, D., et al. (2009) · European Journal of Human Genetics · doi:10.1038/ejhg.2008.154 · Cited by 231
Faivre, L. O., Guardiola, P., Lewis, C. M., Dokal, I. S., Ebell, W., Zatterale, A., Altay, Ç., Poole, J., Stones, D. K., Kwee, M. L., et al. (2000) · PubMed · doi:10.1182/blood.v96.13.4064 · Cited by 226
The DNA crosslink‐induced S‐phase checkpoint depends on ATR–CHK1 and ATR–NBS1–FANCD2 pathways
Pichierri, P., & Rosselli, F. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600113 · Cited by 223
ALDH2 polymorphism and alcohol-related cancers in Asians: a public health perspective
Chang, J. S., Hsiao, J.-R., & Chen, C.-H. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-017-0327-y · Cited by 223
FANCI phosphorylation functions as a molecular switch to turn on the Fanconi anemia pathway
Ishiai, M., Kitao, H., Smogorzewska, A., Tomida, J., Kinomura, A., Uchida, E., Saberi, A., Kinoshita, E., Kinoshita-Kikuta, E., Koike, T., et al. (2008) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1504 · Cited by 222
Van Maldergem, L., Siitonen, H. A., Jalkh, N., Chouery, E., De Roy, M., Delague, V, Muenke, M., Jabs, E. W., Cai, J., Wang, L. L., et al. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2005.031781 · Cited by 217
Aberrant chromosome morphology in human cells defective for Holliday junction resolution
Wechsler, T., Newman, S., & West, S. C. (2011) · Nature · doi:10.1038/nature09790 · Cited by 216
Wagner, J. E. (2004) · Blood · doi:10.1182/blood-2003-09-3138 · Cited by 214
Kashiyama, K., Nakazawa, Y., Pilz, D. T., Guo, C., Shimada, M., Sasaki, K., Fawcett, H., Wing, J. F., Lewin, S. O., Carr, L., et al. (2013) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2013.04.007 · Cited by 212
Thompson, E. R., Doyle, M. A., Ryland, G. L., Rowley, S. M., Choong, D. Y. H., Tothill, R. W., Thorne, H., kConFab, Barnes, D. R., Li, J., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002894 · Cited by 211
Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway
Chirnomas, D., Taniguchi, T., de la Vega, M., Vaidya, A. P., Vasserman, M., Hartman, A.-R., Kennedy, R., Foster, R., Mahoney, J., Seiden, M. V., et al. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0493 · Cited by 207
Klyosov, A. A., Rashkovetsky, L. G., Tahir, M. K., & Keung, W.-M. (1996) · Biochemistry · doi:10.1021/bi9521093 · Cited by 200
Hirsch, B., Shimamura, A., Moreau, L., Baldinger, S., Hag-alshiekh, M., Bostrom, B., Sencer, S., & D'Andrea, A. D. (2004) · Blood · doi:10.1182/blood-2003-06-1970 · Cited by 199
Kais, Z., Rondinelli, B., Holmes, A., O’Leary, C., Kozono, D., D’Andrea, A. D., & Ceccaldi, R. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.05.031 · Cited by 199
Involvement of SLX4 in interstrand cross-link repair is regulated by the Fanconi anemia pathway
Yamamoto, K. N., Kobayashi, S., Tsuda, M., Kurumizaka, H., Takata, M., Kono, K., Jiricny, J., Takeda, S., & Hirota, K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018487108 · Cited by 196
Fanconi anemia: a model disease for studies on human genetics and advanced therapeutics
Bogliolo, M., & Surrallés, J. (2015) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2015.07.002 · Cited by 187
Quentin, S., Cuccuini, W., Ceccaldi, R., Nibourel, O., Pondarre, C., Pagès, M.-P., Vasquez, N., Dubois d'Enghien, C., Larghero, J., Peffault de Latour, R., et al. (2011) · Blood · doi:10.1182/blood-2010-09-308726 · Cited by 187
Exome sequencing identifies FANCM as a susceptibility gene for triple-negative breast cancer
Kiiski, J. I., Pelttari, L. M., Khan, S., Freysteinsdottir, E. S., Reynisdottir, I., Hart, S. N., Shimelis, H., Vilske, S., Kallioniemi, A., Schleutker, J., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1407909111 · Cited by 187
Acetaldehyde and the genome: Beyond nuclear DNA adducts and carcinogenesis
Brooks, P. J., & Zakhari, S. (2013) · Environmental and Molecular Mutagenesis · doi:10.1002/em.21824 · Cited by 179
Application of Bioactive Quercetin in Oncotherapy: From Nutrition to Nanomedicine
Nam, J.-S., Sharma, A., Nguyen, L., Chakraborty, C., Sharma, G., & Lee, S.-S. (2016) · Molecules · doi:10.3390/molecules21010108 · Cited by 179
ATR activation and replication fork restart are defective in FANCM‐deficient cells
Schwab, R. A., Blackford, A. N., & Niedźwiedź, W. (2010) · The EMBO Journal · doi:10.1038/emboj.2009.385 · Cited by 176
Kennedy, R. D., Chen, C. C., Stuckert, P., Archila, E. M., De la Vega, M. A., Moreau, L. A., Shimamura, A., & D’Andrea, A. D. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31245 · Cited by 175
Separate roles for the DNA damage checkpoint protein kinases in stabilizing DNA replication forks
Segurado, M., & Diffley, J. F. X. (2008) · Genes & Development · doi:10.1101/gad.477208 · Cited by 173
Hira, A., Yabe, H., Yoshida, K., Okuno, Y., Shiraishi, Y., Chiba, K., Tanaka, H., Miyano, S., Nakamura, J., Kojima, S., et al. (2013) · Blood · doi:10.1182/blood-2013-06-507962 · Cited by 172
Regulation of kinetochore–microtubule attachments through homeostatic control during mitosis
Godek, K. M., Kabeche, L., & Compton, D. A. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3916 · Cited by 170
Katzke, V. A., Kaaks, R., & Kühn, T. (2015) · The Cancer Journal · doi:10.1097/ppo.0000000000000101 · Cited by 168
A novel Fanconi anaemia subtype associated with a dominant-negative mutation in RAD51
Ameziane, N., May, P., Haitjema, A., van de Vrugt, H. J., van Rossum-Fikkert, S. E., Ristic, D., Williams, G. J., Balk, J., Rockx, D., Li, H., et al. (2015) · Nature Communications · doi:10.1038/ncomms9829 · Cited by 168
Mouse models of Fanconi anemia
Parmar, K., D’Andrea, A., & Niedernhofer, L. J. (2009) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2009.03.015 · Cited by 166
Genetic Heterogeneity among Fanconi Anemia Heterozygotes and Risk of Cancer
Berwick, M., Satagopan, J. M., Ben‐Porat, L., Carlson, A. D., Mah, K., Henry, R., Diotti, R., Milton, K., Pujara, K., Landers, T., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1501 · Cited by 155
Biallelic Deleterious BRCA1 Mutations in a Woman with Early-Onset Ovarian Cancer
Domchek, S. M., Tang, J.-B., Stopfer, J. E., Lilli, D. R., Hamel, N., Tischkowitz, M. D., Monteiro, Á. N. A., Messick, T. E., Powers, J., Yonker, A., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0421 · Cited by 153
Chk1-Mediated Phosphorylation of FANCE Is Required for the Fanconi Anemia/BRCA Pathway
Wang, X., Kennedy, R. D., Ray, K., Stuckert, P., Ellenberger, T., & D’Andrea, A. D. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02357-06 · Cited by 152
Haneline, L. S., Broxmeyer, H. E., Cooper, S., Hangoc, G., Carreau, M., Buchwald, M., & Clapp, D. W. (1998) · Blood · doi:10.1182/blood.v91.11.4092 · Cited by 151
Self-citationDNA and protein adducts in human tissues resulting from exposure to tobacco smoke
Phillips, D. H., & Venitt, S. (2012) · International Journal of Cancer · doi:10.1002/ijc.27827 · Cited by 151
Genotype–phenotype correlations in Fanconi anemia
Neveling, K., Endt, D., Hoehn, H., & Schindler, D. (2009) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2009.05.006 · Cited by 149
Germ Line Fanconi Anemia Complementation Group C Mutations and Pancreatic Cancer
Couch, F. J., Johnson, M. R., Rabe, K. G., Boardman, L., McWilliams, R. R., de Andrade, M., & Petersen, G. M. (2005) · Cancer Research · doi:10.1158/0008-5472.383.65.2 · Cited by 146
Rathbun, R. K., Faulkner, G. R., Ostroski, M. H., Christianson, T. A., Hughes, G., Jones, G., Cahn, R., Maziarz, R., Royle, G., Keeble, W., et al. (1997) · Blood · doi:10.1182/blood.v90.3.974 · Cited by 143
Defective mitochondrial peroxiredoxin-3 results in sensitivity to oxidative stress in Fanconi anemia
Mukhopadhyay, S. S., Leung, K. S., Hicks, J. M., Hastings, P. J., Youssoufian, H., & Plon, S. E. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200607061 · Cited by 142
Rickman, K. A., Lach, F. P., Abhyankar, A., Donovan, F. X., Sanborn, E. M., Kennedy, J. A., Sougnez, C. L., Gabriel, S., Elemento, O., Chandrasekharappa, S. C., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.06.014 · Cited by 141
Rosenberg, P. S., Tamary, H., & Alter, B. P. (2011) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.34087 · Cited by 138
The SLX4 Complex Is a SUMO E3 Ligase that Impacts on Replication Stress Outcome and Genome Stability
Guervilly, J.-H., Takedachi, A., Naim, V., Scaglione, S., Chawhan, C., Lovera, Y., Despras, E., Kuraoka, I., Kannouche, P. L., Rosselli, F., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.11.014 · Cited by 137
The short and long telomere syndromes: paired paradigms for molecular medicine
Stanley, S. E., & Armanios, M. Y. (2015) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2015.06.004 · Cited by 136
The mini-driver model of polygenic cancer evolution
Castro-Giner, F., Ratcliffe, P. J., & Tomlinson, I. P. M. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3999 · Cited by 133
A novel diagnostic screen for defects in the Fanconi anemia pathway
Shimamura, A., Oca, R. M. D., Svenson, J. L., Haining, W. N., Moreau, L. A., Nathan, D. G., & D’Andrea, A. D. (2002) · Blood · doi:10.1182/blood-2002-05-1399 · Cited by 132
Vinciguerra, P., Godinho, S. A., Parmar, K., Pellman, D. S., & D’Andrea, A. D. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43391 · Cited by 130
Biallelic inactivation of REV7 is associated with Fanconi anemia
Bluteau, D., Masliah‐Planchon, J., Clairmont, C. S., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci88010 · Cited by 130
CHK1 inhibition as a strategy for targeting fanconi anemia (FA) DNA repair pathway deficient tumors
Chen, C. C., Kennedy, R. D., Sidi, S., Look, A. T., & D’Andrea, A. D. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-24 · Cited by 129
SUMO Modification Regulates BLM and RAD51 Interaction at Damaged Replication Forks
Ouyang, K. J., Woo, L. L., Zhu, J., Huo, D., Matunis, M. J., & Ellis, N. A. (2009) · PLoS Biology · doi:10.1371/journal.pbio.1000252 · Cited by 128
Evidence of mitochondrial dysfunction and impaired ROS detoxifying machinery in Fanconi Anemia cells
Kumari, U., Jun, W. Y., Bay, B., & Lyakhovich, A. (2013) · Oncogene · doi:10.1038/onc.2012.583 · Cited by 125
TNF-α induces leukemic clonal evolution ex vivo in Fanconi anemia group C murine stem cells
Li, J., Sejas, D. P., Zhang, X., Qiu, Y., Nattamai, K. J., Rani, R., Rathbun, K. R., Geiger, H., Williams, D. A., Bagby, G. C., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31772 · Cited by 124
Gibbs‐Seymour, I., Oka, Y., Rajendra, E., Weinert, B. T., Passmore, L. A., Patel, K. J., Olsen, J. V., Choudhary, C., Bekker‐Jensen, S., & Mailand, N. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.12.001 · Cited by 121
Phosphorylation of FANCD2 on Two Novel Sites Is Required for Mitomycin C Resistance
Ho, G. P. H., Margossian, S. P., Taniguchi, T., & D’Andrea, A. D. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02018-05 · Cited by 120
Mutations in the Gene Encoding the E2 Conjugating Enzyme UBE2T Cause Fanconi Anemia
Hira, A., Yoshida, K., Sato, K., Okuno, Y., Shiraishi, Y., Chiba, K., Tanaka, H., Miyano, S., Shimamoto, A., Tahara, H., et al. (2015) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2015.04.022 · Cited by 115
Fancd2 −/− mice have hematopoietic defects that can be partially corrected by resveratrol
Zhang, Q., Loza, L. I. M., Eaton, L., Duncan, A. W., Goldman, D. C., Anur, P., Watanabe‐Smith, K., Rathbun, R. K., Fleming, W., Bagby, G. C., et al. (2010) · Blood · doi:10.1182/blood-2010-04-278226 · Cited by 114
Hematopoietic stem cell defects in mice with deficiency of Fancd2 or Usp1
Parmar, K., Kim, J., Sykes, S. M., Shimamura, A., Stuckert, P., Zhu, K., Hamilton, A., Deloach, M. K., Kutok, J. L., Akashi, K., et al. (2010) · Stem Cells · doi:10.1002/stem.437 · Cited by 113
Callen, E., Casado, J. A., Tischkowitz, M. D., Bueren, J. A., Creus, A., Marcos, R., Dasí, A., Estella, J. M., Muñoz, A., Ortega, J. J., et al. (2004) · Blood · doi:10.1182/blood-2004-07-2588 · Cited by 113
Easton, D. F., Lesueur, F., Decker, B. J., Michailidou, K., Li, J., Allen, J., Luccarini, C., Pooley, K. A., Shah, M., Bolla, M. K., et al. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2015-103529 · Cited by 109
Sobeck, A., Stone, S., Costanzo, V., de Graaf, B., Reuter, T., de Winter, J. P., Wallisch, M., Akkari, Y. M. N., Olson, S. B., Wang, W., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.26.2.425-437.2006 · Cited by 108
The Fanconi Anemia Polypeptide, FAC, Binds to the Cyclin-Dependent Kinase, cdc2
Kupfer, G. M., Yamashita, T., Näf, D., Suliman, A., Asano, S., & D’Andrea, A. D. (1997) · Blood · doi:10.1182/blood.v90.3.1047 · Cited by 102
Hadjur, S., Ung, K., Wadsworth, L. D., Dimmick, J. E., Rajcan‐Separovic, E., Scott, R. W., Buchwald, M., & Jirik, F. R. (2001) · Blood · doi:10.1182/blood.v98.4.1003 · Cited by 100
Guido Fanconi (1892–1979): a jack of all trades
Lobitz, S., & Velleuer, E. (2006) · Nature reviews. Cancer · doi:10.1038/nrc2009 · Cited by 98
Mondal, G., Rowley, M., Guidugli, L., Wu, J., Pankratz, V. S., & Couch, F. J. (2012) · Developmental Cell · doi:10.1016/j.devcel.2012.05.008 · Cited by 98
FANCD2 limits replication stress and genome instability in cells lacking BRCA2
Michl, J., Zimmer, J., Buffa, F. M., McDermott, U., & Tarsounas, M. (2016) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3252 · Cited by 95
Deletion and reduced expression of the Fanconi anemia FANCA gene in sporadic acute myeloid leukemia
Tischkowitz, M. D., Morgan, N. V., Grimwade, D. J., Eddy, C.-A., Ball, S. E., Vořechovský, I., Langabeer, S. E., Stöger, R. J., Hodgson, S. V., & Mathew, C. G. (2004) · Leukemia · doi:10.1038/sj.leu.2403280 · Cited by 91
BRCA2 Fine-Tunes the Spindle Assembly Checkpoint through Reinforcement of BubR1 Acetylation
Choi, E., Park, P., Lee, H., Lee, Y.-K., Kang, G. H., Lee, J. W., Han, W., Lee, H. C., Noh, D.-Y., Lekomtsev, S., et al. (2012) · Developmental Cell · doi:10.1016/j.devcel.2012.01.009 · Cited by 89
Fanconi anemia type C and p53 cooperate in apoptosis and tumorigenesis
Freie, B. W., Li, X., Ciccone, S. L. M., Nawa, K., Cooper, S. H., Vogelweid, C. M., Schantz, L. D., Haneline, L. S., Orazi, A., Broxmeyer, H. E., et al. (2003) · Blood · doi:10.1182/blood-2003-03-0971 · Cited by 85
Self-citationDirect and indirect roles of RECQL4 in modulating base excision repair capacity
Schurman, S. H., Hedayati, M. A., Wang, Z., Singh, D. K., Speina, E., Zhang, Y., Becker, K. G., Macris, M. A., Sung, P., Wilson, D. M., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp291 · Cited by 85
Collins, N. B., Wilson, J. B., Bush, T., Tomashevski, A., Roberts, K. J., Jones, N. J., & Kupfer, G. M. (2008) · Blood · doi:10.1182/blood-2008-05-154294 · Cited by 84
Ouyang, J., Garner, E., Hallet, A., Nguyen, H. D., Rickman, K. A., Gill, G., Smogorzewska, A., & Zou, L. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.11.015 · Cited by 84
Centrosome dynamics as a source of chromosomal instability
Nam, H.-J., Naylor, R. M., & van Deursen, J. M. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.10.002 · Cited by 83
Saadatzadeh, M. R., Bijangi‐Vishehsaraei, K., Hong, P., Bergmann, H., & Haneline, L. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313721200 · Cited by 83
Renaud, E., Barascu, A., & Rosselli, F. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1019 · Cited by 82
Rathbun, R. K., Christianson, T. A., Faulkner, G. R., Jones, G., Keeble, W. W., O'Dwyer, M. E., & Bagby, G. C. (2000) · Blood · doi:10.1182/blood.v96.13.4204.h8004204_4204_4211 · Cited by 81
Wang, H.-F., Takenaka, K., Nakanishi, A., & Miki, Y. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0030 · Cited by 80
RECQL4 in genomic instability and aging
Croteau, D. L., Singh, D. K., Ferrarelli, L. H., Lu, H., & Bohr, V. A. (2012) · Trends in Genetics · doi:10.1016/j.tig.2012.08.003 · Cited by 77
Maternal Aldehyde Elimination during Pregnancy Preserves the Fetal Genome
Oberbeck, N., Langevin, F., King, G., de Wind, N., Crossan, G. P., & Patel, K. J. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.07.010 · Cited by 74
Fanconi anemia signaling network regulates the spindle assembly checkpoint
Nalepa, G., Enzor, R., Sun, Z., Marchal, C. C., Park, S.-J., Yang, Y., Tedeschi, L., Kelich, S. L., Hanenberg, H., & Clapp, D. W. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67364 · Cited by 74
Self-citationCeccaldi, R., Briot, D., Larghero, J., Vasquez, N., d’Enghien, C. D., Chamousset, D., Noguera, M., Waisfisz, Q., Hermine, O., Pondarré, C., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43836 · Cited by 72
The structure of the catalytic subunit FANCL of the Fanconi anemia core complex
Cole, A. R., Lewis, L., & Walden, H. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1759 · Cited by 70
Virts, E. L., Jankowska, A. M., MacKay, C., Glaas, M. F., Wiek, C., Kelich, S. L., Lottmann, N., Kennedy, F. M., Marchal, C. C., Lehnert, E., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv227 · Cited by 69
Tamary, H., Nishri, D., Yacobovich, J., Zilber, R., Dgany, O., Krasnov, T., Aviner, S., Stepensky, P., Revel‐Vilk, S., Bitan, M., et al. (2010) · Haematologica · doi:10.3324/haematol.2009.018119 · Cited by 69
Du, W., Rani, R., Sipple, J., Schick, J. S., Myers, K. C., Mehta, P. A., Andreassen, P. R., Davies, S. M., & Pang, Q. (2012) · Blood · doi:10.1182/blood-2011-09-381970 · Cited by 68
Kato, Y., Alavattam, K. G., Sin, H., Meetei, A. R., Pang, Q., Andreassen, P. R., & Namekawa, S. H. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv244 · Cited by 68
ATR-Dependent Phosphorylation of FANCM at Serine 1045 Is Essential for FANCM Functions
Singh, T. R., Ali, A. M., Paramasivam, M., Pradhan, A., Wahengbam, K., Seidman, M. M., & Meetei, A. R. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3976 · Cited by 68
Downregulation of Fanconi Anemia Genes in Sporadic Head and Neck Squamous Cell Carcinoma
Wreesmann, V. B., Estilo, C. L., Eisele, D. W., Singh, B., & Wang, S. J. (2007) · ORL · doi:10.1159/000101542 · Cited by 67
Wilson, H., Wilson, J. R., & Fuchs, P. N. (2006) · Brain Research · doi:10.1016/j.brainres.2006.04.088 · Cited by 66
FANCD2 Activates Transcription of TAp63 and Suppresses Tumorigenesis
Park, E., Kim, H., Kim, J. M., Primack, B., Vidal-Cardenas, S. L., Xu, Y., Price, B. D., Mills, A. A., & D’Andrea, A. D. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.05.017 · Cited by 66
TNF-α signaling in Fanconi anemia
Du, W., Erden, O., & Pang, Q. (2013) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2013.06.005 · Cited by 65
Bi‐allelic silencing of the Fanconi anaemia gene FANCF in acute myeloid leukaemia
Tischkowitz, M. D., Ameziane, N., Waisfisz, Q., de Winter, J. P., Harris, R., Taniguchi, T., D’Andrea, A. D., Hodgson, S. V., Mathew, C. G., & Joenje, H. (2003) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.04640.x · Cited by 65
Cuomo, M. E., Knebel, A., MORRICE, N. A., Paterson, H. J., III, Cohen, P., & Mittnacht, S. (2008) · Nature Cell Biology · doi:10.1038/ncb1735 · Cited by 64
Mechanism of DNA interstrand cross-link processing by repair nuclease FAN1
Wang, R., Persky, N. S., Yoo, B., Ouerfelli, O., Smogorzewska, A., Elledge, S. J., & Pavletich, N. P. (2014) · Science · doi:10.1126/science.1258973 · Cited by 63
Alavattam, K. G., Kato, Y., Sin, H., Maezawa, S., Kowalski, I. J., Zhang, F., Pang, Q., Andreassen, P. R., & Namekawa, S. H. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.073 · Cited by 63
Dissecting cancer evolution at the macro-heterogeneity and micro-heterogeneity scale
Barber, L. J., Davies, M. N., & Gerlinger, M. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2014.12.001 · Cited by 62
Pulliam, A. C., Ciccone, S. L. M., Nalepa, G., Li, X., Si, Y. C., Miravalle, L., Smith, D., Yuan, J., Li, J., Anur, P., et al. (2010) · Blood · doi:10.1182/blood-2009-08-240747 · Cited by 61
Self-citationForty Years of Research on Xeroderma Pigmentosum at the US National Institutes of Health
Kraemer, K. H., & DiGiovanna, J. J. (2014) · Photochemistry and Photobiology · doi:10.1111/php.12345 · Cited by 60
Androgen therapy in Fanconi anemia: A retrospective analysis of 30 years in Germany
Paustian, L., Chao, M. M., Hanenberg, H., Schindler, D., Neitzel, H., Kratz, C. P., & Ebell, W. (2016) · Pediatric Hematology and Oncology · doi:10.3109/08880018.2015.1129567 · Cited by 60
Zhi, G., Wilson, J. B., Chen, X., Krause, D. S., Xiao, Y., Jones, N. J., & Kupfer, G. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-2312 · Cited by 58
Qiao, F., Mi, J., Wilson, J. B., Zhi, G., Bucheimer, N. R., Jones, N. J., & Kupfer, G. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408323200 · Cited by 58
Houghtaling, S. R., Newell, A. H., Akkari, Y. M. N., Taniguchi, T., Olson, S. B., & Grompe, M. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi334 · Cited by 57
Park, I., Lee, H.-O., Choi, E., Lee, Y.-K., Kwon, M., Min, J., Park, P.-G., Lee, S., Kong, Y.-Y., Gong, G., et al. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201210099 · Cited by 56
Monoketone analogs of curcumin, a new class of Fanconi anemia pathway inhibitors
Landais, I., Hiddingh, S., McCarroll, M. N., Yang, C., Sun, A., Turker, M. S., Snyder, J. P., & Hoatlin, M. E. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-133 · Cited by 55
Zanier, R., Briot, D., du Villard, J.-A. D., Sarasin, A. R., & Rosselli, F. (2004) · Oncogene · doi:10.1038/sj.onc.1207677 · Cited by 48
Cited by
The BioGRID interaction database: 2019 update
Oughtred, R., Stark, C., Breitkreutz, B.-J., Rust, J., Boucher, L., Chang, C., Kolas, N., O’Donnell, L., Leung, G., McAdam, R., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1079 · Cited by 1,473
Epidemiology of acute myeloid leukemia: Recent progress and enduring challenges
Shallis, R. M., Wang, R., Davidoff, A., Ma, X., & Zeidan, A. M. (2019) · Blood Reviews · doi:10.1016/j.blre.2019.04.005 · Cited by 941
DNA damage-how and why we age?
Yousefzadeh, M., Henpita, C., Vyas, R., Soto-Palma, C., Robbins, P., & Niedernhofer, L. (2021) · eLife · doi:10.7554/elife.62852 · Cited by 399
Platinum Resistance in Ovarian Cancer: Role of DNA Repair
Damia, G., & Broggini, M. (2019) · Cancers · doi:10.3390/cancers11010119 · Cited by 298
Cell fitness screens reveal a conflict between LINE-1 retrotransposition and DNA replication
Ardeljan, D., Steranka, J. P., Liu, C., Li, Z., Taylor, M. S., Payer, L. M., Gorbounov, M., Sarnecki, J. S., Deshpande, V., Hruban, R. H., et al. (2020) · Nature Structural & Molecular Biology · doi:10.1038/s41594-020-0372-1 · Cited by 135
Metadata
- Authors
- Nalepa, G., & Clapp, D. W.
- Venue
- Nature Reviews Cancer
- Published
- 2018-01-29
- Volume
- 18
- Issue
- 3
- Pages
- 168-185
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2784483500
- Cited by
- 389
- References
- 228
- FWCI
- 3.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.